1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Kruskal-Wallis analysis of %BVC among healthy controls, patients with stem cell (MSC) implantation, and MCAI controls
Healthy ControlsMSC ImplantationMCAI Controls
%BVC2.000.736−3.59
95% CI−1.58–5.58−4.15–5.62−12.3 to −5.21
P value compared with healthy controlsaNA.38.06
P value compared with patients with MSC.38NA.09
P value compared with MCAI controls.06.09NA
  • Note:—NA indicates not applicable.
  • ↵a P values from a post hoc pair-wise analysis using the Mann-Whitney U test of the Kruskal-Wallis analysis results.